Obermatt
See Similar Stocks →

OPKO Health

NSQ:OPK · US68375N1037
Health Care Providers & ServicesMedium

360

8
Profit price78
Owner Earnings Yield1
Dividend Yield1
Price/Sales34
EV / Gross Profit7
Price/Book85
Return on Capital8
Cash Return on Capital16
Return on Equity16
EBIT Margin1
Gross Profitability3
Accruals85
Owner Earnings Margin8
Sales growth1
Profit growth1
Reinvestment43
Price momentum46
Debt load73
Refinancing67
Debt Payback1
Liquidity31
Analyst ratings23
Opinion Changes50
Price Target Upside100
Market mood50
Value Creation2/20not creating value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

OPKO Health doesn't consistently earn more than its cost of capital, so it isn't yet creating shareholder value.

Profile

CountryUSA
IndustryHealth Care Providers & Services
SizeMedium
TypePublic Company
ExchangeNASDAQGS
Employees243
Websiteopko.com
ISINUS68375N1037
Last UpdateApr 2, 2026
Indices
NASDAQ (USA)
Themes
Health DiagnosticsDiabetesCardiovascularImmunologyInfectious DiseasesVaccinesOncologyGeneticsWomen's HealthHematologyBiotechnologyPharmaceutical

Description

OPKO Health, Inc. operates as a diversified healthcare company. The company's pharmaceutical business features NGENLA (somatrogon-ghla), also referred to as Somatrogon (hGH-CTP), a once-weekly human growth hormone injection. The company has partnere…

Analysis

Weak and unloved

OPKO Health, Inc. scores below average on quality and is priced accordingly, a low-conviction position in either direction.

Valuation data is not available for this company.

Growth is tepid; the safety picture is adequate. The company scores 2/20 on our value-creation score: not creating value.

No flags apply to this company at this time: accounts, balance sheet, and cash quality all pass. A clean bill of health is meaningful, not just the absence of a warning. This analysis describes numbers; it is not investment advice.

360° rank · history

1007550250
19
2023202420252026

All-time high

77

Jan 2025

All-time low

3

Jan 2023

Average rank

33

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
34
23
31
25
Price/Earnings
80
1
1
1
Price/Book
85
84
85
79
Dividend Yield
1
1
1
1
Value (overall)
65
41
44
18

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare OPKO Health with its peers
Quest Diagnostics
NYQ:DGX
35
CountryUSA
IndustryHealth Care Providers & Services
SizeX-Large
Full Stock Analysis →
DaVita
NYQ:DVA
40
CountryUSA
IndustryHealth Care Providers & Services
SizeX-Large
Full Stock Analysis →
Labcorp
NYQ:LH
40
CountryUSA
IndustryHealth Care Providers & Services
SizeX-Large
Full Stock Analysis →
Fulgent Genetics
NMQ:FLGT
4
CountryUSA
IndustryHealth Care Providers & Services
SizeMedium
Full Stock Analysis →
GeneDx
NSQ:WGS
6
CountryUSA
IndustryHealth Care Providers & Services
SizeMedium
Full Stock Analysis →
NeoGenomics
NAQ:NEO
31
CountryUSA
IndustryHealth Care Providers & Services
SizeMedium
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →